StepStone VC 2025-RX LP is a private equity fund based in Owings Mills, Maryland. According to its most recent Form D, filed May 13, 2025, it has sold $5,000,000 of interests to 2 investors since its first sale in May 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Scott Hart; John Wuestling; John Avirett.
- Total raised
- $5,000,000Cumulative sales reported on Form D
- Investors
- 2
- First sale
- May 1, 2025
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Scott Hart; John Wuestling; John Avirett
- Latest Form D
- May 13, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about StepStone VC 2025-RX LP
What is the minimum investment for StepStone VC 2025-RX LP?
StepStone VC 2025-RX LP's latest Form D, filed May 13, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in StepStone VC 2025-RX LP?
StepStone VC 2025-RX LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has StepStone VC 2025-RX LP raised?
StepStone VC 2025-RX LP reports $5,000,000 sold from 2 investors on its Form D filed May 13, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is StepStone VC 2025-RX LP based?
StepStone VC 2025-RX LP is based in Owings Mills, Maryland.
When did StepStone VC 2025-RX LP launch?
StepStone VC 2025-RX LP reports its first sale in May 2025, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every private equity fund
Raised more than 35% of the 162 private equity funds based in Maryland, and more than 34% of all 9,142 that report sales.
Other funds with the same team
- StepStone VC Secondaries Fund VII-M LP$1.0B
- StepStone VC Global Partners XII (Lux) SCSp, SICAV-RAIF$834M
- StepStone VC Global Partners XII ND LP$834M
- StepStone VC Global Partners XII (Cayman) LP$834M
- StepStone VC Global Partners XII LP$834M
- StepStone VC Micro V LP$157M
- StepStone VC Wabash Fund LP$120M
- StepStone VC Aspen LP$114M